Home › Drug Codes › A Codes › A9582 · ADREVIEW
Updated October 1st, 2026

ADREVIEW A Code: A9582

Iodine i-123 iobenguane, diagnostic, per study dose, up to 15 millicuries

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q4 2026
APC Payment Limit ?
$2,317.50
unchanged, 0.0% since Q3 2026
/ HCPCS billing unitQ3 2026: $2,317.50
ASP ?
No current ASP
Not available for Q4 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
1
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Iodine i-123 iobenguane, diagnostic, per study dose, up to 15 millicuries
HCPCS Added Date January 1, 2010
Manufacturer GE Healthcare
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Injection

About ADREVIEW

Adreview is a medication aligned to the HCPCS A Code: A9582 for billing, pricing, and reimbursement purposes in the United States. This Imaging/Radiopharmaceutical medication is administered via the intravenous route and manufactured by GE Healthcare.

Manufacturers, reach out to us to add more information.

NDC Code Information

1 NDC package is crosswalked to A9582. Package detail is available to logged-in subscribers.

Login to view 1 NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

ADREVIEW Pricing & Reimbursement

A9582 Private Payer Reimbursement
$5,307.40 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

ADREVIEW Medically Unlikely Edits (MUE)

The most billing units of A9582 Medicare will pay for one patient in one day, as published by CMS. 1 unit = up to 15 millicuries.

Practitioner Office & Hospital Outpatient
1 unit / day
Same limit in both settings

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

Not on the CMS JW / JZ list

CMS does not include Adreview (A9582) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing A9582. Wastage billing guide →

Try Pro free for 7 daysUpgrade to ProAdd Analytics and full history with Pro

Pro includes:

  • ASP, WAC and AWP for every drug
  • NDC package pricing
  • 10+ years of price history
  • Side-by-side Analytics in the Comparative Report

Card required · cancel anytime

Frequently Asked Questions

Is there a manufacturer-published billing and coding guide for Adreview?
Our team has not identified a manufacturer-published source of billing and coding information for Adreview.
Are there any available patient assistance programs for Adreview?
Our team has not identified a source of patient assistance information for Adreview.
Where can I find Adreview prescribing information?
Adreview prescribing information can be found at the link below. Visit Here →
Is there available side effect information for Adreview?
Our team has not identified a source of side effect information for Adreview.
Does billing ADREVIEW require JZ/JW wastage modifiers?
CMS does not include ADREVIEW (A9582) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing A9582. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.